Global Fibromyalgia Drugs Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

  • ID:PD006122
  • November 2020
  • Value Market Research
                          

The report on the Global Fibromyalgia Drugs Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of a comprehensive research. The report gives a complete market analysis for the forecasted period from 2021 to 2027. The market is divided into various segments with an in-depth outlook of the competitors and a listing of the profiled key players. The market size in terms of revenue (USD MN) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.

Drivers

  • Increasing cases of rheumatic diseases
  • Growing awareness among the population
  • Rising Geriatric Population
 
Restraints
  • Lack of Infrastructure
 
Furthermore, the report quantifies the market share held by the major players of the industry and provides an in-depth view of the competitive landscape. This market is classified into different segments with detailed analysis of each with respect to geography for the study period:
  • Base Year: 2020
  • Estimated Year: 2021
  • Forecast Till: 2027
 
The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activityinvolved. The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.
 
The report classifies the market into different segments based on drug class and distribution channels. These segments are studied in detail incorporating the market estimates and forecasts at regional and country level. The segment analysis is useful in understanding the growth areas and probable opportunities of the market.
 
The report also covers the complete competitive landscape of the Global Fibromyalgia Drugs market with company profiles of key players such as:
  • Daiichi Sankyo
  • Eli Lilly
  • Innovative Med Concepts
  • Pfizer
  • Theravance Biopharma
  • Forest Pharmaceuticals, Inc.
  • Innovative Med Concepts
  • Meiji Seika Pharma
  • Tonix Pharmaceuticals
A detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.
 
SEGMENTATIONS IN THE REPORT:
By Drug Class
  • Antidepressants
    • Venlafaxine
    • Duloxetine HCl
    • Milnacipran HCl
    • Others
  • Anticonvulsants
    • Pregabalin
    • Gabapentin
    • Others
  • Muscle Relaxants
  • Analgesics
 
By Distribution Channels
  • Hospitals Pharmacies
  • Drug Stores
  • Retail Pharmacies
  • Online Pharmacies
 
By Geography:
  • North America (NA) – US, Canada & Rest of North America
  • Europe (EU) – UK, Germany, France & Rest of Europe
  • Asia Pacific (APAC) – China, Japan, India & Rest of APAC
  • Latin America (LA) – Brazil & Rest of Latin America
  • Middle East &Africa (MEA) – Middle East and Africa
 
The Global Fibromyalgia Drugs Market has been exhibited in detail in the following chapters -
Chapter 1 Fibromyalgia Drugs Market Preface
Chapter 2 Executive Summary
Chapter 3 Fibromyalgia Drugs  Industry Analysis
Chapter 4 Fibromyalgia Drugs Market Value Chain Analysis
Chapter 5 Fibromyalgia Drugs Market Analysis By Drug Class
Chapter 6 Fibromyalgia Drugs Market Analysis By Distribution Channels
Chapter 7 Fibromyalgia Drugs Market Analysis By Geography
Chapter 8 Competitive Landscape Of Fibromyalgia Drugs Companies
Chapter 9 Company Profiles Of Fibromyalgia Drugs Industry

TABLE OF CONTENTS
 
1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Fibromyalgia Drugs Market
       2.2. Global Fibromyalgia Drugs Market Snapshot
 
3 . FIBROMYALGIA DRUGS – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Fibromyalgia Drugs Market
       3.3. Market Restraints of Fibromyalgia Drugs Market
       3.4. Opportunities of Fibromyalgia Drugs Market
       3.5. Trends of Fibromyalgia Drugs Market
       3.6. Porter’s Five Force Analysis of Fibromyalgia Drugs Market
       3.7. Fibromyalgia Drugs Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Drug Class
           3.7.2 Market Attractive Analysis by Distribution Channels
           3.7.3 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Fibromyalgia Drugs Value Chain Analysis
       4.2. Fibromyalgia Drugs Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Fibromyalgia Drugs Raw Material Manufactures List
           4.2.3. Price Trend of Fibromyalgia Drugs Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Fibromyalgia Drugs Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Fibromyalgia Drugs Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Fibromyalgia Drugs Market Size in 2020, by Scenario
       5.5. COVID-19: Micro and Macro Factor Analysis on Fibromyalgia Drugs Market
 
6 . GLOBAL FIBROMYALGIA DRUGS MARKET ANALYSIS BY DRUG CLASS
       6.1 Overview by Drug Class
       6.2 Global Fibromyalgia Drugs Market Analysis by Drug Class
       6.3 Market Analysis of Antidepressants by Regions
       6.4 Market Analysis of Anticonvulsants by Regions
       6.6 Market Analysis of Muscle Relaxants by Regions
       6.5 Market Analysis of Analgesics by Regions
 
7 . GLOBAL FIBROMYALGIA DRUGS MARKET ANALYSIS BY DISTRIBUTION CHANNELS
       7.1 Overview by Distribution Channels
       7.2 Global Fibromyalgia Drugs Market Analysis by Distribution Channels
       7.3 Market Analysis of Hospitals Pharmacies by Regions
       7.4 Market Analysis of Drug Stores by Regions
       7.5 Market Analysis of Retail Pharmacies by Regions
       7.6 Market Analysis of Online Pharmacies by Regions
 
8 . GLOBAL FIBROMYALGIA DRUGS MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview
           8.3.2. North America Fibromyalgia Drugs Market Estimate by Market Segment
           8.3.3. North America Fibromyalgia Drugs Market Estimate by Country
           8.3.4. United State
           8.3.5. Rest of North America
       8.4. Europe
           8.4.1. Overview
           8.4.2. Europe Fibromyalgia Drugs Market Estimate by Market Segment
           8.4.3. Europe Fibromyalgia Drugs Market Estimate by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.8 Rest of Europe
       8.5. Asia Pacific
           8.5.1. Overview
           8.5.2. Asia Pacific Fibromyalgia Drugs Market Estimate by Market Segment
           8.5.3. Asia Pacific Fibromyalgia Drugs Market Estimate by Country
           8.5.4. China
           8.5.5. Japan
           8.5.6. India
           8.5.8. Rest of Asia Pacific
       8.6. Latin America
           8.6.1. Overview
           8.6.2. Latin America Fibromyalgia Drugs Market Estimate by Market Segment
           8.6.3. Latin America Fibromyalgia Drugs Market Estimate by Country
           8.6.4. Brazil
           8.6.5. Rest of Latin America
       8.8. Middle East & Africa
           8.8.1. Overview
           8.8.2. Middle East & Africa Fibromyalgia Drugs Market Estimate by Market Segment
           8.8.3. Middle East & Africa Fibromyalgia Drugs Market Estimate by Country
           8.8.4. Middle East
           8.8.5. Africa
 
9 . COMPETITIVE LANDSCAPE OF THE FIBROMYALGIA DRUGS COMPANIES
       9.1. Fibromyalgia Drugs Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF FIBROMYALGIA DRUGS INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Daiichi Sankyo
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Eli Lilly
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Innovative Med Concepts
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Pfizer
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Theravance Biopharma
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. Forest Pharmaceuticals, Inc.
           10.8.1. Company Overview
           10.8.2. Financials
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. Innovative Med Concepts
           10.9.1. Company Overview
           10.9.2. Financials
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. Meiji Seika Pharma
           10.10.1. Company Overview
           10.10.2. Financials
           10.10.3. Products
           10.10.4. Recent Developments
       10.11. Tonix Pharmaceuticals
           10.11.1. Company Overview
           10.11.2. Financials
           10.11.3. Products
           10.11.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Fibromyalgia Drugs Market Snapshot
  • Drivers of The Global Fibromyalgia Drugs Market Impact Analysis
  • Restraints of The Global Fibromyalgia Drugs Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Fibromyalgia Drugs Market: Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Fibromyalgia Drugs Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on Fibromyalgia Drugs Market
  • Global Fibromyalgia Drugs Market Analysis by Drug Class (USD MN)
  • Global Fibromyalgia Drugs Market Analysis in Antidepressants by Geography (USD MN)
  • Global Fibromyalgia Drugs Market Analysis in Anticonvulsants by Geography (USD MN)
  • Global Fibromyalgia Drugs Market Analysis in Muscle Relaxants by Geography (USD MN)
  • Global Fibromyalgia Drugs Market Analysis in Analgesics by Geography (USD MN)
  • Global Fibromyalgia Drugs Market Analysis by Distribution Channels (USD MN)
  • Global Fibromyalgia Drugs Market Analysis in Hospitals Pharmacies by Geography (USD MN)
  • Global Fibromyalgia Drugs Market Analysis in Drug Stores by Geography (USD MN)
  • Global Fibromyalgia Drugs Market Analysis in Retail Pharmacies by Geography (USD MN)
  • Global Fibromyalgia Drugs Market Analysis in Online Pharmacies by Geography (USD MN)
  • Global Fibromyalgia Drugs Market by Geography (USD MN)
  • North America Fibromyalgia Drugs Market Analysis by Drug Class (USD MN)
  • North America Fibromyalgia Drugs Market Estimate by Distribution Channels (USD MN)
  • North America Fibromyalgia Drugs Market Estimate by Country (USD MN)
  • United State Fibromyalgia Drugs Market Analysis by Drug Class (USD MN)
  • United State Fibromyalgia Drugs Market Estimate by Distribution Channels (USD MN)
  • Rest of North America Fibromyalgia Drugs Market Analysis by Drug Class (USD MN)
  • Rest of North America Fibromyalgia Drugs Market Estimate by Distribution Channels (USD MN)
  • Europe Fibromyalgia Drugs Market Analysis by Drug Class (USD MN)
  • Europe Fibromyalgia Drugs Market Estimate by Distribution Channels (USD MN)
  • United Kingdom Fibromyalgia Drugs Market Analysis by Drug Class (USD MN)
  • United Kingdom Fibromyalgia Drugs Market Estimate by Distribution Channels (USD MN)
  • France Fibromyalgia Drugs Market Analysis by Drug Class (USD MN)
  • France Fibromyalgia Drugs Market Estimate by Distribution Channels (USD MN)
  • Germany Fibromyalgia Drugs Market Analysis by Drug Class (USD MN)
  • Germany Fibromyalgia Drugs Market Estimate by Distribution Channels (USD MN)
  • Rest of Europe Fibromyalgia Drugs Market Analysis by Drug Class (USD MN)
  • Rest of Europe Fibromyalgia Drugs Market Estimate by Distribution Channels (USD MN)
  • Asia Pacific Fibromyalgia Drugs Market Analysis by Drug Class (USD MN)
  • Asia Pacific Fibromyalgia Drugs Market Estimate by Distribution Channels (USD MN)
  • Asia Pacific Fibromyalgia Drugs Market Estimate by Country (USD MN)
  • China Fibromyalgia Drugs Market Analysis by Drug Class (USD MN)
  • China Fibromyalgia Drugs Market Estimate by Distribution Channels (USD MN)
  • Japan Fibromyalgia Drugs Market Analysis by Drug Class (USD MN)
  • Japan Fibromyalgia Drugs Market Estimate by Distribution Channels (USD MN)
  • India Fibromyalgia Drugs Market Analysis by Drug Class (USD MN)
  • India Fibromyalgia Drugs Market Estimate by Distribution Channels (USD MN)
  • Rest of Asia Pacific Fibromyalgia Drugs Market Analysis by Drug Class (USD MN)
  • Rest of Asia Pacific Fibromyalgia Drugs Market Estimate by Distribution Channels (USD MN)
  • Latin America Fibromyalgia Drugs Market Analysis by Drug Class (USD MN)
  • Latin America Fibromyalgia Drugs Market Estimate by Distribution Channels (USD MN)
  • Latin America Fibromyalgia Drugs Market Estimate by Country (USD MN)
  • Brazil Fibromyalgia Drugs Market Analysis by Drug Class (USD MN)
  • Brazil Fibromyalgia Drugs Market Estimate by Distribution Channels (USD MN)
  • Rest of Latin America Fibromyalgia Drugs Market Analysis by Drug Class (USD MN)
  • Rest of Latin America Fibromyalgia Drugs Market Estimate by Distribution Channels (USD MN)
  • Middle East & Africa Fibromyalgia Drugs Market Analysis by Drug Class (USD MN)
  • Middle East & Africa Fibromyalgia Drugs Market Estimate by Distribution Channels (USD MN)
  • Middle East & Africa Fibromyalgia Drugs Market Estimate by Country (USD MN)
  • Middle East Fibromyalgia Drugs Market Analysis by Drug Class (USD MN)
  • Middle East Fibromyalgia Drugs Market Estimate by Distribution Channels (USD MN)
  • Africa Fibromyalgia Drugs Market Analysis by Drug Class (USD MN)
  • Africa Fibromyalgia Drugs Market Estimate by Distribution Channels (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2020
 
LIST OF FIGURES
 
  • Research Scope of Fibromyalgia Drugs Report
  • Market Research Process
  • Market Research Methodology
  • Global Fibromyalgia Drugs Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Drug Class
  • Market Attractiveness Analysis by Distribution Channels
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Fibromyalgia Drugs Market Analysis by Drug Class (USD MN)
  • Global Fibromyalgia Drugs Market Analysis in Antidepressants by Geography (USD MN)
  • Global Fibromyalgia Drugs Market Analysis in Anticonvulsants by Geography (USD MN)
  • Global Fibromyalgia Drugs Market Analysis in Muscle Relaxants by Geography (USD MN)
  • Global Fibromyalgia Drugs Market Analysis in Analgesics by Geography (USD MN)
  • Global Fibromyalgia Drugs Market Analysis by Distribution Channels (USD MN)
  • Global Fibromyalgia Drugs Market Analysis in Hospitals Pharmacies by Geography (USD MN)
  • Global Fibromyalgia Drugs Market Analysis in Drug Stores by Geography (USD MN)
  • Global Fibromyalgia Drugs Market Analysis in Retail Pharmacies by Geography (USD MN)
  • Global Fibromyalgia Drugs Market Analysis in Online Pharmacies by Geography (USD MN)
  • Latin America Fibromyalgia Drugs Market by Revenue
  • Middle East & Africa Fibromyalgia Drugs Market by Revenue
  • Recent Development in Fibromyalgia Drugs Industry
  • Company Market Share Analysis, 2020
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Related Categories
Pharmaceuticals
Related Reports
Global Tigecycline Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Tigecycline Market gives an estimation of the development of the market based on historical studies and also provides forecasts  read more..


Global Risperidone Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

The Global Risperidone Market Report is equipped with market data from 2015 to 2025. The report gives a market overview covering key drivers and risks  read more..


Global Caffeine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Caffeine Market gives an estimation of the development of the market based on historical studies and also provides forecasts on  read more..


Global Rabies Vaccine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Rabies Vaccine Market gives an estimation of the development of the market based on historical studies and also provides  read more..


Global Radiopharmaceuticals Market Insights, Forecast to 2025

Radiopharmaceuticals Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under  read more..


Global Neurorehabilitation System Market Research Report

The report on the Global Neurorehabilitation System Market gives an estimation of the development of the market based on historical studies and also  read more..


Global Molecular Biology Kits And Reagents Market Research Report

The report on the Global Molecular Biology Kits And Reagents Market gives an estimation of the development of the market based on historical studies and  read more..


Global High Acuity Care Information Systems Market Research Report

The report on the Global High Acuity Care Information Systems Market gives an estimation of the development of the market based on historical studies and  read more..


Global Regenerative Medicine Market Research Report

The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013.   A number of factors such as increasing bone related  read more..


Global Skin Cancer Diagnostics Market Research Report

The report on the Global Skin Cancer Diagnostics Market gives an estimation of the development of the market based on historical studies and also  read more..